152 results on '"Seersholm N"'
Search Results
2. α1-Antitrypsin deficiency associated with increased risk of heart failure in two large populations
3. Treatment with methotrexate and risk of lung disease in patients with rheumatoid arthritis:a nationwide population-based cohort study from Denmark
4. Pseudomonas aeruginosa and risk of death and exacerbations in patients with chronic obstructive pulmonary disease:an observational cohort study of 22 053 patients
5. OP0232 TREATMENT WITH METHOTREXATE AND RISK OF LUNG DISEASE IN PATIENTS WITH RHEUMATOID ARTHRITIS: A NATIONWIDE POPULATION-BASED COHORT STUDY FROM DENMARK
6. Use of Inhaled Corticosteroids and Risk of Acquiring Pseudomonas Aeruginosa in Patients with Chronic Obstructive Pulmonary Disease
7. A comparison between QuantiFERON and tuberculin skin test during screening for tuberculosis infection in a contact investigation among students: O310
8. The European Alpha-1 Research Collaboration (EARCO): a new ERS Clinical Research Collaboration to promote research in alpha-1 antitrypsin deficiency
9. α1-Antitrypsin genotype unaffected by age: Authors’ reply
10. Pi MZ and COPD: will we ever know?
11. Short-term Reproducibility of Computed Tomography-based Lung Density Measurements in Alpha-1 Antitrypsin Deficiency and Smokers with Emphysema
12. α1-Antitrypsin deficiency · 1: Epidemiology of α1-antitrypsin deficiency
13. antitrypsin deficiency * 1: epidemiology of [α.sub.1]-antitrypsin deficiency
14. Eosinophil-Guided Corticosteroid-Sparing Therapy in Hospitalized Patients with Exacerbated COPD(CORTICOsteroid Reduction in COPD (CORTICO-COP)): A Randomized Prospective Multicenter Investigator-Initiated Trial
15. The Effect Of Alpha1-Proteinase Inhibitor (a1-Pi) Therapy On Changes In Regional Lung Density: Post-Hoc Analysis Of The Rapid/rapid Extension Trial
16. Malignant neoplasms in pulmonary sarcoidosis
17. Intravenous augmentation treatment and lung density in severe α1 antitrypsin deficiency (RAPID): a randomised, double-blind, placebo-controlled trial
18. Decline in FEV1 among patients with severe hereditary alpha 1-antitrypsin deficiency type PiZ.
19. Survival in relation to lung function and smoking cessation in patients with severe hereditary alpha 1-antitrypsin deficiency.
20. P2074Association between left ventricular diastolic function, pulmonary function and cardiovascular events in the general population
21. Impact of contact investigation and tuberculosis screening among high-risk groups in Denmark
22. Impact of contact investigation and tuberculosis screening among high-risk groups in Denmark
23. Screening for lungecancer med lavdosis-CT kræver grundige overvejelser
24. Screening for lungecancer med lavdosis CT - Danske og udenlandske resultater
25. Randomized clinical trial of alpha(1)-antitrypsin augmentation therapy
26. The Danish Lung Cancer Screening Trial
27. Alpha1-antitrypsin deficiency. 1: epidemiology of alpha1-antitrypsin deficiency.
28. Retninglinier for undersøgelse for latent og aktiv tuberkulose forud for behandling med TNF-a hæmmere
29. Cancer in Patients With Ataxia-Telangiectasia and in Their Relatives in the Nordic Countries
30. Attitudes toward an unsolicited approach in relation to status of genetic disease: Exemplified by ?1-antitrypsin deficiency
31. Transmitting Genetic Risk Information in Families: Attitudes about Disclosing the Identity of Relatives
32. Cancer risk in close relatives of women with early-onset breast cancer – a population-based incidence study
33. Malignant neoplasms in pulmonary sarcoidosis
34. Clinical features and prognosis of life time non-smokers with severe alpha 1-antitrypsin deficiency
35. Intermediate α1-antitrypsin deficiency PiSZ: a risk factor for pulmonary emphysema?
36. Cancer in the offspring of parents with lung cancer
37. Risk of malignant neoplasms in patients with pulmonary sarcoidosis.
38. Does alpha1-antitrypsin augmentation therapy slow the annual decline in FEV1 in patients with severe hereditary alpha1-antitrypsin deficiency? Wissenschaftliche Arbeitsgemeinschaft zur Therapie von Lungenerkrankungen (WATL) alpha1-AT study group
39. Body mass index and mortality in patients with severe α1-antitrypsin deficiency
40. Airways obstruction and two year survival in patients with severe alpha 1-antitrypsin deficiency
41. Survival of patients with severe alpha 1-antitrypsin deficiency with special reference to non-index cases.
42. Attitudes toward an unsolicited approach in relation to status of genetic disease: Exemplified by α<INF>1</INF>-antitrypsin deficiency
43. Clinical features and prognosis of life time non-smokers with severe α1-antitrypsin deficiency
44. Lung cancer screening with low dose CT requires careful consideration
45. [Lung cancer screening with low dose CT requires careful consideration]
46. [Lung cancer screening with low-dose CT - Danish and international results]
47. Malignant neoplasms in pulmonary sarcoidosis [5] (multiple letters)
48. Lung cancer screening with low-dose CT - Danish and international results
49. Cancer in the parents of children with cancer.
50. Systemic antibiotics for Pseudomonas aeruginosa infection in outpatients with non-hospitalised exacerbations of pre-existing lung diseases: a randomised clinical trial.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.